Overall, the most important alterations leading to GBM are TP53, IDH, ATRX, and TERT promoter mutations; CDKN2A-p16INK4a and MGMT promoter hypermethylation; PDGFR expression; and EGFR amplification and/or mutation [12]. Here, CDKN2A is linked to glioblastoma.